These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 7550349
21. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development. Koren-Michowitz M, Friedman E, Gershoni-Baruch R, Brok-Simoni F, Patael Y, Rechavi G, Amariglio N. Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604 [Abstract] [Full Text] [Related]
22. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families. Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L. Cas Lek Cesk; 2000 Oct 11; 139(20):635-7. PubMed ID: 11192759 [Abstract] [Full Text] [Related]
23. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel. Laitman Y, Simeonov M, Herskovitz L, Kushnir A, Shimon-Paluch S, Kaufman B, Zidan J, Friedman E. Breast Cancer Res Treat; 2012 Jun 11; 133(3):1153-7. PubMed ID: 22399190 [Abstract] [Full Text] [Related]
24. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP. Cancer Epidemiol Biomarkers Prev; 2001 Sep 11; 10(9):955-60. PubMed ID: 11535547 [Abstract] [Full Text] [Related]
25. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL. Nat Genet; 1996 May 11; 13(1):123-5. PubMed ID: 8673091 [Abstract] [Full Text] [Related]
29. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E. Br J Cancer; 2000 Aug 11; 83(4):463-6. PubMed ID: 10945492 [Abstract] [Full Text] [Related]
35. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T. Am J Hum Genet; 1997 Mar 11; 60(3):505-14. PubMed ID: 9042909 [Abstract] [Full Text] [Related]
37. Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K. Genet Test; 1997 Mar 11; 1(1):47-51. PubMed ID: 10464625 [Abstract] [Full Text] [Related]